NCT05503095View on ClinicalTrials.gov

PCSK9 Polymorphism and Risk of Cardiac Rupture

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

August 31, 2023

Study Completion Date

May 31, 2024

Conditions
Post-Infarction Heart RuptureGene Polymorphism
Interventions
GENETIC

Genetic analysis for PCSK9 polymorphisms

Determination of PCSK9 gene polymorphism and serum PCSK9 concentration

Trial Locations (1)

21100

RECRUITING

Matteo Matteucci, Varese

All Listed Sponsors
lead

Maastricht University Medical Center

OTHER